Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Investigational Site Number : 3480004, Budapest

Investigational Site Number : 0360001, Darlinghurst

Investigational Site Number : 0360003, Phillip

Investigational Site Number : 0360002, Melbourne

Investigational Site Number : 3480001, Debrecen

Investigational Site Number : 3480002, Szeged

Investigational Site Number : 2500005, La Rochelle

Investigational Site Number : 7240002, Madrid

Corazon USA, LLC (DBA Life Clinical Trials) Site Number : 8400011, Margate

Florida International Research Center Site Number : 8400016, Miami

University of South Florida Site Number : 8400012, Tampa

Investigational Site Number : 7240006, Las Palmas de Gran Canaria

Centricity Research Site Number : 8400009, Dublin

Investigational Site Number : 3800002, Cona (Ferrara)

Investigational Site Number : 2760002, Bochum

Investigational Site Number : 2760001, Münster

Investigational Site Number : 2500001, Reims

Washington University School of Medicine Site Number : 8400007, St Louis

Investigational Site Number : 2500003, Lyon

Vast Skin Specialists Site Number : 8400015, Addison

Investigational Site Number : 2500004, Rouen

Stryde Research Epiphany Dermatology Site Number : 8400014, Southlake

Center for Clinical Studies, LTD. LLP Site Number : 8400001, Houston

Investigational Site Number : 2500002, Saint-Mandé

Investigational Site Number : 3800001, Catania

Investigational Site Number : 1520003, Santiago

Investigational Site Number : 1520001, Santiago

Investigational Site Number : 1520002, Santiago

Medical Dermatology Specialists Site Number : 8400002, Phoenix

Center for Dermatology Clinical Research Site Number : 8400010, Fremont

Beth Israel Deaconess Medical Center Site Number : 8400006, Boston

Clinical Partners, LLC Site Number : 8400003, Johnston

Investigational Site Number : 1240007, Barrie

Investigational Site Number : 1240002, Hamilton

Investigational Site Number : 1240001, Québec

Investigational Site Number : 6160001, Warsaw

Investigational Site Number : 6160004, Warsaw

Investigational Site Number : 6160003, Wroclaw

Investigational Site Number : 6200002, Lisbon

Investigational Site Number : 6200001, Lisbon

Investigational Site Number : 7240001, Barcelona

Investigational Site Number : 7240003, Badalona